全文获取类型
收费全文 | 1181篇 |
免费 | 88篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 65篇 |
妇产科学 | 30篇 |
基础医学 | 119篇 |
口腔科学 | 30篇 |
临床医学 | 193篇 |
内科学 | 230篇 |
皮肤病学 | 33篇 |
神经病学 | 53篇 |
特种医学 | 246篇 |
外科学 | 88篇 |
综合类 | 25篇 |
预防医学 | 54篇 |
眼科学 | 9篇 |
药学 | 46篇 |
中国医学 | 5篇 |
肿瘤学 | 48篇 |
出版年
2023年 | 11篇 |
2021年 | 18篇 |
2020年 | 11篇 |
2019年 | 10篇 |
2018年 | 25篇 |
2017年 | 16篇 |
2016年 | 23篇 |
2015年 | 26篇 |
2014年 | 31篇 |
2013年 | 34篇 |
2012年 | 25篇 |
2011年 | 31篇 |
2010年 | 46篇 |
2009年 | 65篇 |
2008年 | 37篇 |
2007年 | 18篇 |
2006年 | 19篇 |
2005年 | 9篇 |
2004年 | 12篇 |
2003年 | 25篇 |
2002年 | 27篇 |
2001年 | 27篇 |
2000年 | 12篇 |
1999年 | 22篇 |
1998年 | 51篇 |
1997年 | 55篇 |
1996年 | 64篇 |
1995年 | 48篇 |
1994年 | 45篇 |
1993年 | 50篇 |
1992年 | 20篇 |
1991年 | 8篇 |
1990年 | 16篇 |
1989年 | 35篇 |
1988年 | 31篇 |
1987年 | 34篇 |
1986年 | 37篇 |
1985年 | 26篇 |
1984年 | 20篇 |
1983年 | 13篇 |
1982年 | 24篇 |
1981年 | 14篇 |
1980年 | 8篇 |
1979年 | 9篇 |
1978年 | 5篇 |
1977年 | 15篇 |
1976年 | 12篇 |
1975年 | 18篇 |
1973年 | 7篇 |
1966年 | 4篇 |
排序方式: 共有1277条查询结果,搜索用时 15 毫秒
1.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
2.
3.
4.
5.
6.
7.
Dr. Heinrich Dickel Otto Blome Karl-Heinz Hagemann Hans Joachim Schwanitz Oliver Kuss Swen Malte John 《Trauma und Berufskrankheit》2003,5(1):109-118
The dermatologist's procedure was introduced in 1972 by employers' liability insurance funds in the industrial, agricultural and public sectors of Germany's statutory occupational accident insurance as a "procedure for early detection of occupational skin diseases". So far, it is still the most relevant tool for secondary prevention in occupational dermatology in Germany. According to the intention of this procedure, insured persons with a skin disease in which an occupational aetiology is suspected must be offered preventive measures and, if necessary, given appropriate treatment to avoid their losing their jobs. On the initiative of the Central Federation of Industrial Professional Associations (HVBG), a study group was set up in 1999 from among its membership in cooperation with the Working Committee of Occupational and Environmental Dermatology (ABD) and the Professional Organisation of German Dermatologists (BVDD) to improve on the efficiency of the "classic" dermatologist's procedure. The proposed "optimised" dermatologist's procedure is based on the assumption that early detection followed by competent and intensified skin protection and skin care will be successful in retarding or stopping the progression of occupational dermatoses, while later treatment is likely to be less effective. In October 2002, a pilot study started in Northwest Germany to establish by scientific evaluation whether the implementation of secondary protective measures is definitively better when the provisional "optimised" dermatologist's procedure is followed. The study results should allow detailed suggestions for an improved dermatologist's procedure before it is introduced nationwide. 相似文献
8.
9.
10.